Session Information
AABB Annual Meeting and CTTXPO 2012
Click here to go to the previous page
The Efficacy of Therapeutic Plasma Exchange in Various Pediatric Diseases: Tales from the Trenches 
Track
:
TC - Technical/Clinical
Program Code:
9219-TC
Date:
Sunday, October 7, 2012
Time:
2:00 PM to 3:30 PM
EST
Location:
204A/B
DIRECTOR
:
Dr. Kelley Capocelli, MD, Medical Director, Transfusion Medicine Services, Children's Hospital Colorado
MODERATOR
:
Dr. Deborah Sesok-Pizzini, MD, MBA, Medical Director, Blood Bank, University of Pennsylvania
SPEAKER
(S):
Dr. Kelley Capocelli, MD, Medical Director of Transfusion Medicine Services, Children's Hospital Colorado
Edward Wong, MD, Associate Director of Transfusion Medicine/Director of Hematology, Children's National Medical Center
David Friedman, MD, Associate Medical Director of Transfusion Service, Children's Hospital of Philadelphia
Description
This session will discuss the use of therapeutic plasma exchange in a variety of clinical settings. The first speaker will describe the utility of therapeutic plasma exchange in the setting of pediatric neurological disorders, discussing important clinical factors to take into consideration when performing plasma exchange in this patient population. The second speaker will discuss the pathophysiology of multisystem organ failure associated with sepsis, using an evidence-based approach to evaluate the utility of plasma exchange and other treatment modalities for this disease. Finally, the third speaker will discuss the role of plasma exchange in support of pediatric patients undergoing renal and cardiac transplantation, including its use in the settings of pretransplant alloimmunization and acute and chronic allograft rejection and for the treatment of recurrent focal sclerosing glomerulonephritis in the renal allograft.
Dr. Wong did not consent to presentation capturing and recording
Dr. Wong did not consent to presentation capturing and recording
- Describe the utility of therapeutic plasma exchange in the setting of pediatric neurological disorders.
- Identify the pathophysiology of multisystem organ failure associated with sepsis and the utility of plasma exchange and other treatments for this disease.
- List the indications for the use of plasma exchange in the setting of pretransplant alloimmunization and for the treatment of acute and chronic allograft rejection.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
Online Access
(Code: 9219-TCAM/9219-TCM/9219-TCA/9219-TC)
Annual Meeting Attendee/AABB Member:$25 USD
Non-Attendee/AABB Member:$40 USD
Annual Meeting Attendee/Non AABB Member:$40 USD
Non-Attendee/Non AABB Member $50 USD - Your Price
This session is a part of:
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |